EUVIMEDEUVIMED entdecken
Video/AudioStudienprotokoll

Trans-Mitochondrial Cybrid Generation from mtDNA Patient Platelets: An Efficient Protocol Optimizing Colony Selection and Functional Validation

Donna M Iadarola, Jarelis Cabrera, Eiko Nakamaru-Ogiso, Marni J Falk

Journal of Visualized Experiments · 2026

DOI: 10.3791/71632 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Donna M Iadarola und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mitochondrial Medicine Frontier Program, Division of Genetic and Genomic Medicine, Department of Pediatrics, The Children's Hospital of Philadelphia. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Blood Platelets, Hybrid Cells, Mitochondria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trans-mitochondrial cybrid cell line generation represents the gold-standard method for determining pathogenicity by enabling biochemical analyses of a specific mitochondrial DNA (mtDNA) variant of interest at high and low percentages (heteroplasmy levels) within an otherwise identical mtDNA and nuclear genome background. Historically, the cybrid generation process has been tedious and poorly efficient. Here, we describe a highly efficient and effective protocol for generating trans-mitochondrial cybrid cell lines by fusing human platelets with a standard osteosarcoma 143B cell line to provide an isogenic nuclear background depleted of mtDNA (Rho0 cells). Cell isolates capture a given mtDNA genome of interest to establish stable cell lines harboring different degrees of heteroplasmy, or to compare divergent effects of distinct mitochondrial haplogroups. Because cybrids from mitochondrial patients may be more difficult to establish with standard protocols, this current methodology focuses on isolating mtDNA variants where the electron transport chain activity is affected. We here demonstrate that colony selection techniques reduce time and improve the yield of generating high-level heteroplasmy mtDNA mutant cybrid lines. A case study is provided of cybrid generation for a variant of unknown significance in MT-ND1, m.3985G>A (p.E227K). We analyze the efficiency of the cybrid generation process using this protocol and run functional studies performed by high-resolution respirometry. High-level heteroplasmy MT-ND1 m.3985G>A cybrid mutants generated by this protocol are shown to have impaired complex I-dependent mitochondrial respiration relative to wild-type control, demonstrating m.3985G>A is likely pathogenic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialBlood PlateletsHybrid CellsMitochondriaHumansCell Line, TumorOsteosarcoma

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Mitochondrial Medicine Frontier Program, Division of Genetic and Genomic Medicine, Department of Pediatrics, The Children's Hospital of Philadelphia.
  • Mitochondrial Medicine Frontier Program, Division of Genetic and Genomic Medicine, Department of Pediatrics, The Children's Hospital of Philadelphia; Department of Pediatrics, University of Pennsylvania Perelman School…

Zitieren

APA

Iadarola, D. M., Cabrera, J., Nakamaru-Ogiso, E., & Falk, M. J. (2026). Trans-Mitochondrial Cybrid Generation from mtDNA Patient Platelets: An Efficient Protocol Optimizing Colony Selection and Functional Validation. Journal of Visualized Experiments. https://doi.org/10.3791/71632

Vancouver

Iadarola DM, Cabrera J, Nakamaru-Ogiso E, Falk MJ. Trans-Mitochondrial Cybrid Generation from mtDNA Patient Platelets: An Efficient Protocol Optimizing Colony Selection and Functional Validation. Journal of Visualized Experiments. 2026. doi:10.3791/71632

BibTeX
@article{Iadarola2026,
  author = {Iadarola, Donna M and Cabrera, Jarelis and Nakamaru-Ogiso, Eiko and Falk, Marni J},
  title = {Trans-Mitochondrial Cybrid Generation from mtDNA Patient Platelets: An Efficient Protocol Optimizing Colony Selection and Functional Validation},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71632}
}
Kostenlos starten →